EU Approves Takeda's £46B Shire Deal With Drug Sale
Europe's competition watchdog on Tuesday greenlighted Japanese pharmaceutical giant Takeda's £46 billion ($60 billion) buy of Dublin's Shire, provided it sells Shire's inflammatory bowel disease drug to a buyer that will...To view the full article, register now.
Already a subscriber? Click here to view full article